CC
Chemours Co
Chemours Co historical holders
total: 5
Trian Fund Management Chemours Co transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2015 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q4
Nelson Peltz has been an institutional investor in Chemours Co (CC) since 2015 Q3. According to 2026 Q1 report, Nelson Peltz doesn't hold any shares. The fund/company first acquired CC in 2015 Q3, initially purchasing about 4.88M shares. Since the initial investment, Trian Fund Management has made 1 more transaction in this position.
When did Nelson Peltz exit their CC position?
Nelson Peltz no longer holds Chemours Co (CC). They sold off their entire position in 2015 Q4, closing out an investment that began in 2015 Q3.
When did Nelson Peltz first invest in CC?
Nelson Peltz first invested in Chemours Co (CC) in 2015 Q3 at the reported quarter-end price of $6.47 per share, acquiring 4,879,376 shares in their initial purchase.
What is Nelson Peltz's average cost basis for CC?
Based on historical transaction data, Nelson Peltz's estimated cost basis for Chemours Co (CC) is approximately $6.47 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $6.47
- Weighted AVG sell price:
- $6.47
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.